MNKD-201, an inhaled formulation of nintedanib for IPF, was shown to be safe and well tolerated in a clinical trial with ...
Columnist Sam Kirton encourages the IPF community to get a jump on legislative advocacy before the new congressional term begins.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback